Genmab is seeking to out-license HuMax-TAC, a human antibody with potential application in autoimmune disease, oncology and organ transplantation.

A Non-Confidential Brochure is available.

A confidential data package is available after execution of a suitable non-disclosure agreement (CDA). Interested parties may request a one way CDA or a two way CDA.

Registered users may access the Confidential Data Room here.